Skip to the checklist or briefing

Berkeley Care Checklist California care in checkboxes

Berkeley, California

Care briefing · Peptides in plain words

What do people mean by “peptide care”?

Start with the actual product. A broad treatment name leaves too much unanswered.

The word tells you less than it seems

Peptides are short chains of tiny building blocks, like a short string of beads. Proteins are made from these building blocks too.

A product’s name, by itself, establishes neither its safety nor whether it is supplied lawfully.

  • Ask for the exact medicine name.
  • Ask how it comes: for example, a pill or an injection (a shot).
  • Ask which health problem the product is intended to address.

An approved medicine

For US drug products, the reviewing agency is the Food and Drug Administration, called FDA throughout this guide.

As of September 26, 2026, FDA-approved medicines included semaglutide (Ozempic) for type 2 diabetes, which involves high blood sugar. Semaglutide (Wegovy) was approved for weight control. Tirzepatide (Mounjaro) also had approval for type 2 diabetes. Tirzepatide (Zepbound) had approval for weight control.

  • Ask the person treating you for the exact product name.
  • Ask which approved use applies to that product.
  • Ask why this option is being considered in your case.

A medicine made to order

To meet a particular patient’s needs, a doctor or pharmacist makes or mixes medicine; that process is called compounding.

On September 26, 2026, compounded medicines were not approved by FDA.

For these medicines, FDA reviews of quality, benefits, and safety do not take place before they are sold.

  • Ask what need a ready-made medicine cannot meet.
  • Ask who makes the medicine.
  • Ask why this particular version is being proposed.

A product labelled for research

The warning from FDA, checked September 26, 2026, concerns weight-loss products promoted for people to take despite “for research purposes” labelling or a “not for human consumption” label.

“Not for human consumption” means not for a person to take. This warning is about products sold for people to take despite those labels.

According to the agency, these products could be harmful and their quality remains unknown.

  • Bring the product name or advert into the care discussion.
  • Ask whether this is an approved medicine, a medicine made for a patient, or a product labelled only for research.
  • Get the pharmacy’s name from the service, then check that name in the state licence search.